Page 9 - Biodesix Nodify Lung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biodesix nodify lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biodesix Nodify Lung Today - Breaking & Trending Today

Reviewing Biodesix (BDSX) & Its Competitors

Biodesix (NASDAQ:BDSX – Get Rating) is one of 44 public companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Biodesix to related businesses based on the strength of its valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings. Valuation & Earnings This table compares […] ....

United States , Biodesix Worksafe , Bio Rad Laboratories Inc , Elston Technologies Inc , Biodesix Inc , Get Rating , Given Biodesix , Nodify Lung Nodule Risk Assessment , Bio Rad Laboratories , Elston Technologies , Biodesix Daily , Nasdaq Bdsx , Stock Comparison , Stock Analysis ,

Philips Incorporates Biodesix blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis

Philips Incorporates Biodesix blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis ....

Privacy Policy , Lood Based Proteomic Nodule Risk Assessment Testing , Lung Cancer Orchestrator , Lung Cancer Diagnosis , Ealth Press Release ,

Royal Philips: Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis

June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis ....

District Of Columbia , United States , Noord Holland , Scott Hutton , Philips Oncologyto , Kathy Oreilly , International Agency For Research On Cancer , Philips Global Press Office , World Health Organization , Genscript Inc , International Early Lung Cancer Action Program Investigators , Philips Lung Cancer Orchestrator , Cancer Orchestratorlung , Biodesix Nodify Lung , Lung Cancer , Chief Executive Officer , Lung Cancer Orchestrator , Cancer Orchestratoris , World Health , Early Lung Cancer Action Program , Nodify Lung , Diagnostic Cortex , Artificial Intelligence , Pass Neutralization Test Kit , Cancer Orchestrator ,

Biodesix, Inc. (NASDAQ:BDSX) Expected to Post Quarterly Sales of $8.60 Million

Wall Street brokerages expect that Biodesix, Inc. (NASDAQ:BDSX – Get Rating) will report $8.60 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Biodesix’s earnings, with estimates ranging from $8.11 million to $8.90 million. Biodesix reported sales of $11.89 million during the same quarter last year, which […] ....

United States , Matthew Strobeck , John Patience , Morgan Stanley , Chicago Capital , Zacks Investment Research , Biodesix Inc , Biodesix Company Profile Get Rating , Canaccord Genuity Group , Millennium Management , Wall Street , Get Rating , Investment Research , Genuity Group , Director Matthew Strobeck , Chairman John Patience , Capital Management , Sigma Investments , Company Profile , Nodify Lung Nodule Risk Assessment , Nasdaq Bdsx ,

Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Buy" from Analysts

Biodesix, Inc. (NASDAQ:BDSX – Get Rating) has received an average recommendation of “Buy” from the seven research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target among […] ....

United States , Matthew Strobeck , John Patience , Geode Capital Management , Zacks Investment Research , Biodesix Inc , Blackrock Inc , De Shaw Co , Jpmorgan Chase Co , Wells Fargo Company , Canaccord Genuity Group , Get Rating , Marketbeat Ratings , Investment Research , Chairman John Patience , Director Matthew Strobeck , Capital Management , Nodify Lung Nodule Risk Assessment , Nasdaq Bdsx ,